NEW YORK (GenomeWeb) – Molecular diagnostics firm T2 Biosystems this week filed with the US Securities and Exchange Commission to sell up to $100 million of its common stock through one or more future offerings.

According to the filing, the company is also seeking SEC approval for certain undisclosed shareholders to sell up to $43 million of the company's common stock from time to time. T2 said that it would not receive any of the proceeds from the sale of these securities.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.